The recent 2016 annual meeting of the Society for Imaging Informatics in Medicine (SIIM) in Portland, Ore., featured many key topics pertinent to this industry’s future growth. While there, I had the opportunity to discuss several of these issues with top industry leaders. 

The American Society for Radiation Oncology (ASTRO) announced the press program for its 58th Annual Meeting, Sept. 25-28 in Boston. The program includes multiple reports from phase III clinical trials, researchers from leading institutions in the United States and abroad, and examinations of a range of cancer types and patient populations. Researchers will share their findings in a series of briefings held on-site at the Boston Convention & Exhibition Center and webcast to registered press.

September 7, 2016 — Toshiba America Medical Systems Inc. announced that its Aplio 500 Platinum ultrasound system will be used during a live case following the International Contrast Ultrasound Society (ICUS) Bubbles Conference, Sept. 8-9 in Chicago. The demonstration is meant to show the benefits of the recent U.S.

September 7, 2016 — Blue Earth Diagnostics announced that the first post-U.S. Food and Drug Administration (FDA) approval, commercial administrations of AxuminTM (fluciclovine F 18) injection occurred recently at Northside Hospital of Atlanta.

Athletes warm up before a workout or game. But how might intellectuals get ready? There may be a way. And it may involve smartphones.

Fetal MRI image on Philips Ingenia 1.5T
Fetal MRI image slider

In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood. 

Navidea Biopharmaceuticals Inc. announced that it has executed a Letter of Intent (LOI) with Cardinal Health for the sale of all rights, title and interest to Navidea’s Lymphoseek product. The agreement covers all U.S. Food and Drug Administration (FDA)-approved, pending and future oncology diagnostic indications in North America, subject to certain limitations, as well as certain other related assets. Under the terms of the LOI, Navidea would receive $80 million at closing, with future consideration tied to annual sales of the Lymphoseek product and certain sales-based milestones. Total consideration to Navidea would be capped at $310 million.

September 6, 2016 — IBA (Ion Beam Applications S.A.) and RaySearch Laboratories have entered into a long-term strategic alliance to combine their respective technologies and advance adaptive proton therapy.

autism severity, diagnostic ultrasound, link, UW stud, genetics

September 2, 2016 — For children with autism and a class of genetic disorders, diagnostic ultrasound exposure in the first trimester of pregnancy is linked to increased autism severity, according to a new study. The study was conducted by researchers at University of Washington (UW) Medicine, UW Bothell and Seattle Children's Research Institute.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now